BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22888681)

  • 1. [Is there an universal artificial tear?].
    Turu L
    Oftalmologia; 2012; 56(1):14-9. PubMed ID: 22888681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency.
    Liu Z; Pflugfelder SC
    Ophthalmology; 1999 May; 106(5):939-43. PubMed ID: 10328393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
    Salib GM; McDonald MB; Smolek M
    J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of artificial tears on tear stress test.
    Khanal S; Simmons PA; Pearce EI; Day M; Tomlinson A
    Optom Vis Sci; 2008 Aug; 85(8):732-9. PubMed ID: 18677237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of artificial tears on visual performance in subjects with dry eye.
    Ridder WH; Tomlinson A; Paugh J
    Optom Vis Sci; 2005 Sep; 82(9):835-42. PubMed ID: 16189494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions.
    Enzenauer RW; Kao A; Williams T; Lambert RW
    Eye Contact Lens; 2003 Oct; 29(4):238-40. PubMed ID: 14555900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A simple method, for tear production stimulation in dry eye].
    Petranyi P
    Klin Monbl Augenheilkd; 2004 Jun; 221(6):520. PubMed ID: 15236118
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of the tear film in the optical quality of the human eye.
    Montés-Micó R
    J Cataract Refract Surg; 2007 Sep; 33(9):1631-5. PubMed ID: 17720082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of two lipid emulsion eyedrops in increasing tear film lipid layer thickness.
    Scaffidi RC; Korb DR
    Eye Contact Lens; 2007 Jan; 33(1):38-44. PubMed ID: 17224677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
    Benelli U; Nardi M; Posarelli C; Albert TG
    Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of artificial tear formulation for patients with dry eye: where do we start?
    Tong L; Petznick A; Lee S; Tan J
    Cornea; 2012 Nov; 31 Suppl 1():S32-6. PubMed ID: 23038032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
    Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
    Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OCT assessment of tear meniscus after punctal occlusion in dry eye disease.
    Ibrahim OM; Dogru M; Kojima T; Matsumoto Y; Wakamatsu TH; Tsubota K; Fujishima H
    Optom Vis Sci; 2012 May; 89(5):E770-6. PubMed ID: 22466101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast sensitivity and tear layer aberrometry in dry eye patients.
    Ridder WH; LaMotte J; Hall JQ; Sinn R; Nguyen AL; Abufarie L
    Optom Vis Sci; 2009 Sep; 86(9):E1059-68. PubMed ID: 19648840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye.
    Nichols JJ; Bickle KM; Zink RC; Schiewe MD; Haque RM; Nichols KK
    Eye Contact Lens; 2012 Mar; 38(2):73-9. PubMed ID: 22157392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new therapy concept for the treatment of dry eye--the usefulness of phospholipid liposomes].
    Lee S; Dausch S; Maierhofer G; Dausch D
    Klin Monbl Augenheilkd; 2004 Oct; 221(10):825-36. PubMed ID: 15499517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of castor oil emulsion eyedrops on tear film composition and stability.
    Maïssa C; Guillon M; Simmons P; Vehige J
    Cont Lens Anterior Eye; 2010 Apr; 33(2):76-82. PubMed ID: 19963428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in ocular aberrations after instillation of artificial tears in dry-eye patients.
    Montés-Micó R; Cáliz A; Alió JL
    J Cataract Refract Surg; 2004 Aug; 30(8):1649-52. PubMed ID: 15313286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a rabbit model of tear film instability and evaluation of viscosity of artificial tear preparations.
    Nakamura S; Okada S; Umeda Y; Saito F
    Cornea; 2004 May; 23(4):390-7. PubMed ID: 15097136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.